Is Kexing Pharmaceuticals putting the brakes on generic drugs? Insiders say that the adjustment of centralized procurement is reshaping the interests landscape and also pushing companies to innovate.

Golden Ten Data reported on October 22 that recently, Kelun Pharmaceutical replied in writing that the company did not give up the industrialization construction project of innovative preparation production line, NDDS and anti-tumor preparations, but only changed the order of use of raised funds according to business needs. Kelun Pharmaceutical emphasized that at present, the company has a production line, which can not only meet the needs of market sales, but also undertake external commissioned processing, and change the investment direction of raised funds in order to further consolidate the core competitiveness in the field of infusion. In the view of the founder of the pharmaceutical company, centralized procurement is a process of readjusting the pattern of interests. "This has led many of the original strong traditional pharmaceutical companies to transform into innovative drugs, because they can't do it without innovation." (per warp)